Satsuma Pharmaceuticals, Inc. (STSA) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es THL Equity Advisors VI, LLC con 854,575,000 acciones. Otros tenedores destacados incluyen Thomas H. Lee Equity Fund VI, L.P. y TAKANASHI KEN.
STSA Participación de Insiders
Principal Titular
THL Equity Advisors VI, LLC
854,575,000 acciones
Compras (12 meses)
0
$0.00 valor
Ventas (12 meses)
0
$0.00 valor
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Thl Equity Advisors Vi, Llc |
10 Percent Owner |
854,575,000 |
2010-11-24 |
|
| 2 |
Thomas H. Lee Equity Fund Vi, L.p. |
10 Percent Owner |
470,908,524 |
2010-11-24 |
|
| 3 |
Takanashi Ken |
10 Percent Owner |
24,847,694 |
2023-06-08 |
|
| 4 |
Shin Nippon Biomedical Laboratories, Ltd. |
10 Percent Owner |
22,053,581 |
2023-06-08 |
|
| 5 |
Kollins John A |
President and CEO |
505,000 |
2022-06-07 |
|
| 6 |
Commodore Capital Lp |
Director |
461,286 |
2022-11-16 |
|
| 7 |
Albrecht Detlef |
Chief Medical Officer |
190,000 |
2022-06-07 |
|
| 8 |
O'neil Thomas P. |
Chief Financial Officer |
190,000 |
2022-06-07 |
|
| 9 |
Leonard Braden Michael |
Director |
150,000 |
2022-11-23 |
|
| 10 |
Stanley Heidi B |
CEO/chair of Sterling Savings |
70,212 |
2009-10-15 |
|
| 11 |
Lukatch Heath |
Director |
30,000 |
2022-06-07 |
|
| 12 |
King Thomas Braxton |
Director |
30,000 |
2022-06-07 |
|
| 13 |
Sandoval Elisabeth |
Director |
30,000 |
2022-06-07 |
|
| 14 |
Shah Rajeev M. |
Director |
30,000 |
2022-06-07 |
|
| 15 |
Riebe Michael T |
Director |
30,000 |
2022-06-07 |
|
| 16 |
Soloway Thomas P |
Director |
30,000 |
2022-06-07 |
|
| 17 |
Harsch Mutya |
Director |
30,000 |
2022-06-07 |
|
| 18 |
Ra Capital Management, L.p. |
10 Percent Owner |
30,000 |
2022-06-07 |
|
| 19 |
Seibly John Gregory |
CEO/president - Sfc |
15,784 |
2014-04-08 |
|
| 20 |
Depillo David S |
EVP/vice Chairman |
9,771 |
2014-04-08 |
|
No hay datos de propiedad disponibles para STSA.
